BioSpace News Archive

HT-2 microscope facilitates three-dimensional fluorescence and optical diffraction tomography of live cells with minimal stress on cells

Botanix receives R&D Tax Incentive refund of A$4.6m

Elto Pharma is developing eltoprazine, which is in Phase IIb clinical development for Parkinson’s disease levodopa-induced dyskinesias, or Parkinson’s LID.

The prevalence of allergic diseases has increased significantly over the last decades, creating substantial financial and societal burdens. Due to this, researchers are trying to discover new approaches to the prevention and treatment of these diseases.

EIB financing strengthens F2G´s research and innovation

MDxHealth SA today announces that the New York State Department of Health has approved its SelectMDx test for Prostate Cancer.

MorphoSys AG announced today that its licensee’s affiliate, Janssen Pharmaceutical K.K. (Janssen) reported that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Tremfya(R) (guselkumab) for the treatment of patients with palmoplantar pustulosis who are not responding or are refractory to existing treatments.

People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows.

Next step: Developing therapies to restore the gene product

A team of scientists from Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) has identified a new approach to cancer therapeutics by targeting the evolution of cancer cells.